American Journal Of Cardiovascular DrugsSCIE

文章摘录

• Cost-Effectiveness of Adding Empagliflozin to Standard Treatment for Heart Failure with Preserved Ejection Fraction Patients in China Author: Lou, Yake; Hu, Tianyang; Huang, Jing Journal: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. 2023; Vol. 23, Issue 1, pp. 47-57. DOI: 10.1007/s40256-022-00550-9
• Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry Author: Millesimo, Michele; Elia, Edoardo; Marengo, Giorgio; De Filippo, Ovidio; Raposeiras-Roubin, Sergio; Wanha, Wojciech; Abu-Assi, Emad; Kinnaird, Tim; Ariza-Sole, Albert; Liebetrau, Christoph; Manzano-Fernandez, Sergio; Iannaccone, Mario; Henriques, Jose Paulo Simao; Templin, Christian; Wilton, Stephen B.; Velicki, Lazar; Xanthopoulou, Ioanna; Correia, Luis; Cerrato, Enrico; Rognoni, Andrea; Nunez-Gil, Ivan; Song, Xiantao; Kawaji, Tetsuma; Quadri, Giorgio; Huczek, Zenon; Paz, Rafael Cobas; Juanatey, Jose Ramon Gonzalez; Nie, Shao-Ping; Kawashiri, Masa-Aki; Dominguez-Rodriguez, Alberto; Conrotto, Federico; D'Ascenzo, Fabrizio; De Ferrari, Gaetano Maria Journal: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. 2023; Vol. 23, Issue 1, pp. 77-87. DOI: 10.1007/s40256-022-00554-5
• Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial Author: Zhou, Qiang; Wang, Zhiqiang; Wang, Heming; Chen, Zhidong; Li, Xiaoyi; Dai, Xiangrong; Zhang, Yong; Yu, Xiaohui; Zhou, Renpeng; Hu, Wei Journal: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. 2023; Vol. 23, Issue 1, pp. 101-112. DOI: 10.1007/s40256-022-00562-5
• Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity Author: Feng, Jie; Wu, Yanqing Journal: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. 2023; Vol. 23, Issue 3, pp. 231-246. DOI: 10.1007/s40256-023-00573-w
• Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis Author: Zheng, Nan; Zhong, Jinyan; Chen, Xi; Su, Jia; Liu, Chengjiang; Jiang, Longfu Journal: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. 2023; Vol. 23, Issue 3, pp. 257-267. DOI: 10.1007/s40256-023-00574-9
• Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021 Author: Hao, Jun; Li, Chen; Li, Junrong; Wang, Chuangshi; Li, Yang; He, Chen; Liu, Weida; Li, Sidong; Zuo, Ling; Hui, Wen Journal: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. 2023; Vol. 23, Issue 3, pp. 301-310. DOI: 10.1007/s40256-023-00575-8
• Effects of Rosuvastatin and Aspirin on Retinal Vascular Structures in Hypercholesterolemic Patients with Low-to-Moderate Risk of Coronary Artery Disease Author: Li Li, Shuang Wang, Huilian Huang, Yi Cai, Yutao Xi, Ying Bai, Changsheng Ma Journal: American Journal of Cardiovascular Drugs, 2019, Vol., , DOI:10.1007/s40256-019-00330-y
• The Efficacy and Safety of Aerosolized Iloprost in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis Author: Hongyu Kuang, Qiang Li, Qijian Yi, Tiewei Lu Journal: American Journal of Cardiovascular Drugs, 2019, Vol., , DOI:10.1007/s40256-018-00324-2